MODERNA expands, UK, Canada and Australia plants
At 27 December 2022 at 07:08 , Anonymous said...
https://www.theguardian.com/politics/2020/nov/17/rishi-sunak-refuses-to-say-if-he-will-profit-from-moderna-covid-vaccine
When Fishys' company was an early adopter of Moderna stock, it is worth noting Moderna had no products, patents or customers whatsoever. Therefore, why would any institutional investor throw 'buckets of money' at a company that had no providence.
Maybe it was an early collaboration with DARPA that helped. DARPA (Defense Advanced Research Projects Agency) a research and development agency of the United States Department of Defense responsible for the development of emerging technologies for military use. In October 2013 DARPA awarded Moderna $25 million to research and develop potential mRNA medicines to primarily support vaccine and antibody programs for protection against Chikungunya.
Equally, in 2013 under the Obama administration, at the same time DARPA and Moderna were 'cosying up', DARPA launched the BRAIN Initiative; BRAIN is an acronym for Brain Research Through Advancing Innovative Neurotechnology. This program involves the development of brain-computer interface technologies for the military, particularly injectable systems. Various methods have been proposed for achieving this, including: optogenetics, magnetogenetics, ultrasound, implanted electrodes, and; transcranial electromagnetic stimulation. Their goal is to obtain read or read-write capability over neurons.
Perhaps we should consider AstraZenec with whom they have been working with since 2013. This partnership provides AstraZeneca with exclusive rights and licenses to research, develop and commercialise potential mRNA medicines that target cardiovascular disease and cancers. Unfortunately in later years AZ rolled out their Covid vaccine that had high instances of endothelial infection and complications (the likely reason for its quiet withdrawal from the market). Endothelial cells are the ceramic like, super smooth cells which line the cardiovascular system. If these cells become diseased or inflamed they can cause strokes, TIAs, pulmonary embolism, DVTs, heart attacks to name but a few. Therefore, suffice to say there new treatment for cardiovascular diseases seemed to have had the opposite effect.
Next, we have BARDA (Biomedical Advanced Research and Development Authority), a U.S. Department of Health responsible for the procurement and development of medical countermeasures. This collaboration came under public scrutiny with regards their generous donations to a fledgling biotech, namely, Moderna. In September 2016, Moderna received an award of approximately $125 million from BARDA to help fund the Zika vaccine program.
Of course, who could possibly forget Bill & Melinda Gates. In January 2016, Moderna entered a global health project framework agreement with The Bill & Melinda Gates Foundation to advance mRNA-based development projects for various infectious diseases.
Collaborations aside, I nearly forgot what I was rambling on about. The UK Government now has a strategic partnership (collaboration) with Moderna at the behest of Mr Sunak. A full spectrum investor who had the foresight to invest in a company that had nothing more than a name. Fast forward 10 years and we find the 'early bird' does indeed catch the worm. Mr Sunak is now able to sign tax payer cheques for his favourite company. Just as well he managed to become the Prime Minister of the United Kingdom just seven years after being 'parachuted' into the safest seat in the country. After a short stay at 11 Downing Street (just enough time to bankrupt us), he became Prime Minister after a brief Coup d'etat. A statement from the UK Government website reads:
"UK cements 10-year-partnership with Moderna in major boost for vaccines and research".
"Moderna to invest in mRNA research and development (R&D) in the UK, and build a state-of-the-art vaccine manufacturing centre with the ability to produce up to 250 million vaccines a year".
Finally, a long, over-used statement is thus: FOLLOW THE MONEY!
https://www.theguardian.com/politics/2020/nov/17/rishi-sunak-refuses-to-say-if-he-will-profit-from-moderna-covid-vaccine
When Fishys' company was an early adopter of Moderna stock, it is worth noting Moderna had no products, patents or customers whatsoever. Therefore, why would any institutional investor throw 'buckets of money' at a company that had no providence.
Maybe it was an early collaboration with DARPA that helped. DARPA (Defense Advanced Research Projects Agency) a research and development agency of the United States Department of Defense responsible for the development of emerging technologies for military use. In October 2013 DARPA awarded Moderna $25 million to research and develop potential mRNA medicines to primarily support vaccine and antibody programs for protection against Chikungunya.
Equally, in 2013 under the Obama administration, at the same time DARPA and Moderna were 'cosying up', DARPA launched the BRAIN Initiative; BRAIN is an acronym for Brain Research Through Advancing Innovative Neurotechnology. This program involves the development of brain-computer interface technologies for the military, particularly injectable systems. Various methods have been proposed for achieving this, including: optogenetics, magnetogenetics, ultrasound, implanted electrodes, and; transcranial electromagnetic stimulation. Their goal is to obtain read or read-write capability over neurons.
Perhaps we should consider AstraZenec with whom they have been working with since 2013. This partnership provides AstraZeneca with exclusive rights and licenses to research, develop and commercialise potential mRNA medicines that target cardiovascular disease and cancers. Unfortunately in later years AZ rolled out their Covid vaccine that had high instances of endothelial infection and complications (the likely reason for its quiet withdrawal from the market). Endothelial cells are the ceramic like, super smooth cells which line the cardiovascular system. If these cells become diseased or inflamed they can cause strokes, TIAs, pulmonary embolism, DVTs, heart attacks to name but a few. Therefore, suffice to say there new treatment for cardiovascular diseases seemed to have had the opposite effect.
Next, we have BARDA (Biomedical Advanced Research and Development Authority), a U.S. Department of Health responsible for the procurement and development of medical countermeasures. This collaboration came under public scrutiny with regards their generous donations to a fledgling biotech, namely, Moderna. In September 2016, Moderna received an award of approximately $125 million from BARDA to help fund the Zika vaccine program.
Of course, who could possibly forget Bill & Melinda Gates. In January 2016, Moderna entered a global health project framework agreement with The Bill & Melinda Gates Foundation to advance mRNA-based development projects for various infectious diseases.
Collaborations aside, I nearly forgot what I was rambling on about. The UK Government now has a strategic partnership (collaboration) with Moderna at the behest of Mr Sunak. A full spectrum investor who had the foresight to invest in a company that had nothing more than a name. Fast forward 10 years and we find the 'early bird' does indeed catch the worm. Mr Sunak is now able to sign tax payer cheques for his favourite company. Just as well he managed to become the Prime Minister of the United Kingdom just seven years after being 'parachuted' into the safest seat in the country. After a short stay at 11 Downing Street (just enough time to bankrupt us), he became Prime Minister after a brief Coup d'etat. A statement from the UK Government website reads:
"UK cements 10-year-partnership with Moderna in major boost for vaccines and research".
"Moderna to invest in mRNA research and development (R&D) in the UK, and build a state-of-the-art vaccine manufacturing centre with the ability to produce up to 250 million vaccines a year".
Finally, a long, over-used statement is thus: FOLLOW THE MONEY!
posted by Anon @ 07:12
9 Comments
9 Comments:
https://www.theguardian.com/politics/2020/nov/17/rishi-sunak-refuses-to-say-if-he-will-profit-from-moderna-covid-vaccine
When Fishys' company was an early adopter of Moderna stock, it is worth noting Moderna had no products, patents or customers whatsoever. Therefore, why would any institutional investor throw 'buckets of money' at a company that had no providence.
Maybe it was an early collaboration with DARPA that helped. DARPA (Defense Advanced Research Projects Agency) a research and development agency of the United States Department of Defense responsible for the development of emerging technologies for military use. In October 2013 DARPA awarded Moderna $25 million to research and develop potential mRNA medicines to primarily support vaccine and antibody programs for protection against Chikungunya.
Equally, in 2013 under the Obama administration, at the same time DARPA and Moderna were 'cosying up', DARPA launched the BRAIN Initiative; BRAIN is an acronym for Brain Research Through Advancing Innovative Neurotechnology. This program involves the development of brain-computer interface technologies for the military, particularly injectable systems. Various methods have been proposed for achieving this, including: optogenetics, magnetogenetics, ultrasound, implanted electrodes, and; transcranial electromagnetic stimulation. Their goal is to obtain read or read-write capability over neurons.
Perhaps we should consider AstraZenec with whom they have been working with since 2013. This partnership provides AstraZeneca with exclusive rights and licenses to research, develop and commercialise potential mRNA medicines that target cardiovascular disease and cancers. Unfortunately in later years AZ rolled out their Covid vaccine that had high instances of endothelial infection and complications (the likely reason for its quiet withdrawal from the market). Endothelial cells are the ceramic like, super smooth cells which line the cardiovascular system. If these cells become diseased or inflamed they can cause strokes, TIAs, pulmonary embolism, DVTs, heart attacks to name but a few. Therefore, suffice to say there new treatment for cardiovascular diseases seemed to have had the opposite effect.
Next, we have BARDA (Biomedical Advanced Research and Development Authority), a U.S. Department of Health responsible for the procurement and development of medical countermeasures. This collaboration came under public scrutiny with regards their generous donations to a fledgling biotech, namely, Moderna. In September 2016, Moderna received an award of approximately $125 million from BARDA to help fund the Zika vaccine program.
Of course, who could possibly forget Bill & Melinda Gates. In January 2016, Moderna entered a global health project framework agreement with The Bill & Melinda Gates Foundation to advance mRNA-based development projects for various infectious diseases.
Collaborations aside, I nearly forgot what I was rambling on about. The UK Government now has a strategic partnership (collaboration) with Moderna at the behest of Mr Sunak. A full spectrum investor who had the foresight to invest in a company that had nothing more than a name. Fast forward 10 years and we find the 'early bird' does indeed catch the worm. Mr Sunak is now able to sign tax payer cheques for his favourite company. Just as well he managed to become the Prime Minister of the United Kingdom just seven years after being 'parachuted' into the safest seat in the country. After a short stay at 11 Downing Street (just enough time to bankrupt us), he became Prime Minister after a brief Coup d'etat. A statement from the UK Government website reads:
"UK cements 10-year-partnership with Moderna in major boost for vaccines and research".
"Moderna to invest in mRNA research and development (R&D) in the UK, and build a state-of-the-art vaccine manufacturing centre with the ability to produce up to 250 million vaccines a year".
Finally, a long, over-used statement is thus: FOLLOW THE MONEY!
There needs to be a referendum on the use of such vaccines. 250 million vaccines a year is a ridiculous over-supply for the UK, pretty much a ridiculous over-supply for the EU. Moderna's Covid vaccine was a complete waste of money, a clinical failure and it is a criminal waste of taxpayers' money for any UK government to waste further money on untested nonsense from the William Gates-backed rip-off company.
History repeats ....Taxpayers looted again..
The World Health Organization, which classes Tamiflu as an essential medicine, said: "We welcome a new and rigorous analysis of available data, and look forward to consideration of its findings after it appears."
Tamiflu: Millions wasted on flu drug, claims major report
10 April 2014
Hundreds of millions of pounds may have been wasted on a drug for flu that works no better than paracetamol, a landmark analysis has said.
The UK has spent £473m on Tamiflu, which is stockpiled by governments globally to prepare for flu pandemics.
The Cochrane Collaboration claimed the drug did not prevent the spread of flu or reduce dangerous complications, and only slightly helped symptoms.
https://www.bbc.co.uk/news/health-26954482
Another justification for stockpiling was to slow the spread of the disease to give time for a vaccine to be developed. The report's authors said "the case for this is simply unproven" and "there is no credible way these drugs could prevent a pandemic".
It also claimed that the drug had a number of side-effects, including nausea, headaches, psychiatric events, kidney problems and hyperglycaemia.
Carl Heneghan, Professor of Evidence-Based Medicine at the University of Oxford and one of the report's authors, told the BBC: "I think the whole £500m has not benefited human health in any way and we may have harmed people.
"The system that exists for producing evidence on drugs is so flawed and open to misuse that the public has been misled."
Dr Tom Jefferson, a clinical epidemiologist and former GP, said: "I wouldn't give it for symptom relief, I'd give paracetamol."
The Cochrane Collaboration researchers have not placed the blame on any individual or organisation, instead saying there had been failings at every step from the manufacturers to the regulators and government.
.................
Tamiflu was widely used during the swine flu outbreak
Another justification for stockpiling was to slow the spread of the disease to give time for a vaccine to be developed. The report's authors said "the case for this is simply unproven" and "there is no credible way these drugs could prevent a pandemic".
It also claimed that the drug had a number of side-effects, including nausea, headaches, psychiatric events, kidney problems and hyperglycaemia.
Carl Heneghan, Professor of Evidence-Based Medicine at the University of Oxford and one of the report's authors, told the BBC: "I think the whole £500m has not benefited human health in any way and we may have harmed people.
"The system that exists for producing evidence on drugs is so flawed and open to misuse that the public has been misled."
Research and production of medicines and vaccines is far too important to be left in the hands of these ruthless corporations. Their aim is to generate ever-increasing profits – not safe and effective treatments.
A socialist government would nationalise the pharmaceutical industry, with compensation only to small shareholders in genuine need. The industry could then be integrated with the NHS.
https://www.socialistparty.org.uk/articles/18478/16-04-2014/tamiflu-scandal-exposes-bloodsucking-big-pharma/
Putin targets Scotland - According to Daily Express foreign policy expert Azeem Ibrahim.
Foreign policy expert Azeem Ibrahim told Express.co.uk Scottish independence would put the UK in a "very bizarre, dangerous situation".
We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
Scottish independence would "dramatically compromise" UK national security, a foreign policy expert has claimed, arguing Vladimir Putin could attempt to assert control over Scotland. Foreign policy expert Azeem Ibrahim told Express.co.uk Scottish independence would put the UK in a "very bizarre, dangerous situation". He explained: "In the current economic environment, an independent Scotland is going to get an economic shock - interest rates would have to go up, there is a massive deficit they would have to fill.
https://www.express.co.uk/news/politics/1710036/Scottish-independence-UK-security-Vladimir-Putin-Scotland-Nicola-Sturgeon
What is omitted by the Daily Express ... The potential for our expert working towards an agenda.
Prof Azeem Ibrahim OBE
Outside academia, Azeem has been a reservist in the IV Battalion Parachute Regiment (UK's elite airborne infantry reserve) and a multi-award winning entrepreneur. He was ranked as a Top 100 Global Thinker by the European Social Think Tank in 2010 and named a Young Global Leader by the World Economic Forum.
With a PhD from the University of Cambridge, Dr Ibrahim has advised many world leaders on policy development and has served as an International Security Fellow at Kennedy School of Government at Harvard, a World Fellow at Yale and a Rothermere Fellow at the University of Oxford.
Dr Ibrahim is also an award winning entrepreneur and his many years of experience in business and policy led him to consider the situation of his own home country. He knew that innovative policy solutions were required if Scotland was to remain globally competitive, and he responded to this need by setting up The Scotland Institute think tank.
https://scottish-business.uk/about-us/dr-azeem-ibrahim-2/
The most remarkable Glaswegian A citizen of both the US and the UK Dr Azeem Ibrahim.
Where does he find the time for all of this ?
Chairman, Ibrahim Foundation
Dr Azeem Ibrahim is Executive Chairman of The Scotland Institute, Chairman of The Ibrahim Foundation, a Fellow and Member of the Board of Directors at the Institute of Social Policy and Understanding and an international advisor on policy issues.
Born and raised in Scotland, Azeem moved from teaching himself to spot good investments in the newspapers he read in his father’s shop to a fast-paced business career. Possessed with an unstoppable work ethic, he set up a series of innovative finance companies in three continents, all before his 32nd birthday. By 2006 he was the youngest person on both the Sunday Times Scots’ Rich List and Cater Anderson’s UK Power 100 list, which called him “one of the most influential and highest achieving people in Britain.”
His commitment to relentless goal setting and challenges led him to a seven-year commitment as a reservist in the IV Battalion Parachute Regiment — the British army’s elite airborne infantry. An equally intense passion for education earned him three Master’s degrees and a PhD in Geopolitical Strategy from the University of Cambridge.
A gifted and respected counsellor, he has offered strategic advice to a number of world leaders, on topics ranging from anti-radicalization to improving social mobility and national competitiveness.
The academic world has taken notice of his accomplishments. Glasgow Caledonian University honoured him with an honorary doctorate. He received appointments from institutions as prestigious as Harvard University where he served as a research scholar at the International Security Program at the Kennedy School of Government. He was selected as a member of the University of Chicago’s Harris School of Public Policy’s Dean’s International Council and as a member of the Board of Directors at the Institute for Social Policy and Understanding. Yale University chose him as an ‘Emerging World Leader’ as part of their World Fellows Program. The World Economic Forum named him a ‘Young Global Leader’ and the LSDP European Social Think Tank tapped him as a ‘Top 100 Global Thinker’. Azeem’s columns are regularly published around the world, and can be read in Foreign Policy, The Scotsman and the Sunday Herald, The Middle East Times, The Huffington Post, Chicago Tribune and the LA Times.
Azeem devotes much of his time to his own charities. In addition to his community grant-giving foundation – the Ibrahim Foundation – he has founded charities that tackle problems as diverse as family and marriage breakdown in Scotland and providing clean drinking water in disaster areas.
"Some cultures refer to teachers as nation builders and see them as higher beings. The Global Teacher Prize was founded to universalize such ideas. I'm excited to join the movement of teacher champions and shout 'teachers matter'!
https://globalteacherprize.org/news/the-judging-academy-gtp/486/486-Azeem-Ibrahim
Other interests
For seven years until early 2006, Azeem was a reservist in the IV Battalion Parachute Regiment – the British army's elite airborne infantry reserve where they are trained to be inserted by parachute behind enemy lines at short notice. A citizen of both the US and the UK, he is a fitness fanatic keen on marathon and fell running, and speaks four languages. Both of Azeem's parents were from Lahore in Pakistan and he still maintains a strong connection with his extended family by visiting Pakistan on a regular basis.
https://101pakistanis.com/azeem
Ticking every anti Putin/Russian talking point in a single article, the astonishing Azeem Ibrahim
May 2022
Russia’s War in Ukraine Could Become Genocide
Moscow is already carrying out ethnic cleansing.
Azeem Ibrahim is a columnist at Foreign Policy, a research professor at the Strategic Studies Institute at the U.S. Army War College, and a director at the Newlines Institute for Strategy and Policy in Washington, D.C. He is the author of Radical Origins: Why We Are Losing the Battle Against Islamic Extremism and The Rohingyas: Inside Myanmar’s Hidden Genocide.
Twitter: @azeemibrahim
Further research required - why mRNA vaccines were a R & D project 10 years ago. Quote: "An acute viral infection with chronic sequelae is not unprecedented. Following our experience with post-chikungunya status, we were struck by the similarities between the long-lasting manifestations after COVID-19 and those after chikungunya virus infection, especially for general and mental disorders, impaired quality of life, and medico-social consequences. Post-chikungunya consequences might account for about 70% of disability-adjusted life-years following a chikungunya outbreak.2, 3 It took about 10 years to describe the post-chikungunya disorders and propose guidelines (still not evidenced-based).4 Despite multi-continental outbreaks, there are still fewer than five well designed randomised-controlled trials, and no management strategy exists for patients who have been suffering post-chikungunya consequences for years. One reason for this neglect of the chronicity of chikungunya is a tendency to consider it a simple, short-lived infection like dengue. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133766/
Brazil CHIKV Quote: "up to 67.9% of individuals in the region had contracted chikungunya. Many of these people were diagnosed as COVID-19 positive, after February 2020, when testing for COVID-19 became possible in the region.6 Therefore, recently, cases of chikungunya and COVID-19 could have been diagnosed interchangeably, leading to incorrect diagnoses." https://onlinelibrary.wiley.com/doi/10.1002/jmv.26952?fbclid=IwAR3zsgvOuacua08uP5_W7tUKSBpQJGpBeFZmcYzMTcmsiEPZhepkH8io7K8
Brazil CHIKV Quote: "up to 67.9% of individuals in the region had contracted chikungunya. Many of these people were diagnosed as COVID-19 positive, after February 2020, when testing for COVID-19 became possible in the region.6 Therefore, recently, cases of chikungunya and COVID-19 could have been diagnosed interchangeably, leading to incorrect diagnoses." https://onlinelibrary.wiley.com/doi/10.1002/jmv.26952?fbclid=IwAR3zsgvOuacua08uP5_W7tUKSBpQJGpBeFZmcYzMTcmsiEPZhepkH8io7K8
Post a Comment
Subscribe to Post Comments [Atom]
<< Home